A recent study published in Addiction evaluated the associations of cannabis use disorder (CUD) with cardiovascular disease (CVD) outcomes.
FDA explains why it rejected Vanda’s insomnia application as company faces takeover bid
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS